Press Releases

May 28, 2019 7:00am EDT

CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

May 22, 2019 8:41am EDT

CollPlant Launches New HQ and R&D Center in Israel

Apr 24, 2019 3:28pm EDT

CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care

Apr 23, 2019 7:00am EDT

CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City

Apr 01, 2019 1:14pm EDT

CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update

Mar 18, 2019 8:00am EDT

CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics

Mar 11, 2019 7:00am EDT

Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks

Feb 19, 2019 6:00am EST

CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body

Dec 10, 2018 9:04am EST

Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow

Nov 29, 2018 8:07am EST

CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update